Skip to content

Light as an Aid for Recovery in Psychiatric Inpatients

Light as an Aid for Recovery in Psychiatric Inpatients: A Pragmatic Randomized Controlled Pilot Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02653040
Enrollment
54
Registered
2016-01-12
Start date
2015-12-15
Completion date
2018-03-15
Last updated
2018-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Illness

Keywords

Lighting, Inpatients, Recovery, Sleep

Brief summary

The purpose of this pilot study is to evaluate wether a naturalistic indoor light environment can improve sleep and mood in psychiatric inpatients

Detailed description

Setting: 17 bed inpatient ward at a University Mental Health Hospital Rooms: The dimensions of all 17 rooms are identical with 4,54m x 3,14m, ceiling height 3,15m, a window, a bed, a table, a chair and a bathroom 1,55m x 1,85m. Assignment of interventions: After admission patients are invited to participate in the study. If the patients wish to participate they will go through eligibility screen, sign informed consent and fill out questionnaires on sleep, mood and well-being (-t1). The patients (now participants) are randomly allocated (t0) by sealed envelope technique and the envelope is brought to the staff office and opened by a staff member who then from the computer in the office programs the participant's room to either intervention or control. Randomization: The investigators used random permuted blocks of varying and blinded block size. A third party person created the envelopes and arranged them in blocks. Blinding: The outcome assessor and data analyst is blinded to allocation. Trial participants and care providers are unblinded. Participants may be replaced to another room for practical, clinical reasons. In this case, the intervention/control conditions will follow the patient. Data management: All data will be entered in RedCAP and stored in a electronic online secured database at Aarhus University. Power estimation: Alfa: 0.05. Beta: 0.20. Effect size: change of 4 points in PSQI with a standard deviation estimated to 4. Number of patients in each arm: 17 (x 2 = 34). Number needed to be included accounting for discontinuation: 60 (estimated) Statistics: The investigators will calculate intention-to-treat. Other statistical analyses will include logistic regression for dichotomous outcome data, analysis of covariance for continuous outcome data, and survival analysis for time-to-event outcome data. Interim-analyses during the data-collection period to stop trial if intervention produces larger than expected benefits or harm or if investigators find evidence of no important difference between experimental and control interventions.

Interventions

Intervention is rooms with light settings imitating natural light conditions with white light at day and low-lux no-blue light at night: 07am-10am: white light, increasing intensity 10am-07pm: white light, full intensity 07pm-11pm: no blue wavelength, low intensity 11pm-07am: no blue wavelength, very low intensity

Sponsors

Aarhus University Hospital
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 68 Years
Healthy volunteers
No

Inclusion criteria

* Admission

Exclusion criteria

* Inability to provide written consent * Mania

Design outcomes

Primary

MeasureTime frame
Sleep quality on the Pittsburgh Sleep Quality Index (PSQI)Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months

Secondary

MeasureTime frameDescription
Well-being on the World Health Organization measure of well-being (WHO-5)Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
Depressive symptoms on the Major depression inventory (MDI)Answers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months
Qualitative assessment using a custom made questionnaireAnswers from questionnaires are assessed through study completion, an average of 1 month, up to 6 monthsNumber of patients with side-effects.
Sleep diaryAnswers from questionnaires are assessed through study completion, an average of 1 month, up to 6 months

Other

MeasureTime frameDescription
Use of medication from logged activity in the electronic medical recordAssessed through study completion, an average of 1 month, up to 6 monthsUse of medication during admission including drug og dosages administered to the participants in mg/day.
Involuntary restraintsAssessed through study completion, an average of 1 month, up to 6 monthsNumber of participants who experienced involuntary physical and/or medical restraints.
Time to dischargeAssessed through study completion, an average of 1 month, up to 6 monthsNumber of days between admission and discharge

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026